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1. Introduction
  Malaria remains a potent threat to public health especially 
along the Thailand border regions, with Plasmodium vivax 
(P. vivax) being one of the human malaria species causing 
significant malaria morbidity. Drug treatment is still 
effective for this parasite in Thailand, meanwhile malaria 
vaccines are being developed and a key factor determining 
their likely efficacy is the extent of genetic variation in the 
population[1]. The genetic diversity of P. vivax is less well 
studied than that of P. falciparum but studies have recently 
started to redress this imbalance since completion of the 
genome project for P. vivax in 2008[2]. Data on genetic 
structure are important because gene flow between malaria 
transmission sites and 
recombination of different allele types are involved in the 
spread of drug resistance and, potentially, in the evolution 
of drug sensitivity. The investigation and comparison 
of parasite genetics between populations can quantify 
the geographical distribution of genetic polymorphisms, 
which can be used to monitor existing interventions or 
inform vaccine formulation based on malaria endemicity. 
Genetic studies of P. vivax in Asia showed more diversity 
than South-American populations[3], whereas African 
populations of P. falciparum are highly genetically 
diverse[4]. 
  Several genetic markers in P. vivax have been identified, 
mainly through their role in vaccine development, that can 
be used to study genetic diversity such as apical membrane 
antigen 1(AMA1), Merozoite surface protein 1 (MSP1), 
merozoite surface protein 3 alpha, beta, gamma (MSP3毩,
MSP3毬, MSP3毭), and circumsporozoite protein (CSP). 
However PvAMA1 and PvMSP3 genes show limited sequence 
polymorphism and display limited genetic diversity within 
a geographic region[5,6] PvMSP1 is highly polymorphic so 
is a suitable marker for molecular analysis and also for 
detecting multiple infections[7]. Previous studies of the 
PvCSP gene have revealed three variant types; VK210[8], 
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VK247[9] and P. vivax-like[10]. The most predominant type 
was VK210 with most of the remainder distributed between 
VK210 and VK247, and P. vivax-like variant type was rarely
found[11-15]. The variation of PvCSP gene in different regions 
may be due to parasite/host interactions in the Anopheline 
vectors and human population[16]. Analysis of PvMSP1, 
revealed six variable blocks[17]. Imwong et al. found size 
variation in PvMSP1 block 2 and 10 and a total of 23 allelic 
types for blocks 6-8[18]. Genetic diversity studies of PvMSP1 
and PvCSP genes have been performed in India, Iran and 
Afghanistan as well as Thailand[18-21], but a comparison 
between regions in Thailand has not previously been 
undertaken. Both PvCSP and PvMSP1 genes are currently 
vaccine candidates for P. vivax and were selected in this 
study to investigate P. vivax genetic diversity in Thailand. 
Knowledge of P. vivax allelic polymorphism is needed to 
define the epidemiologic distribution of P. vivax strains 
and to aid the development of an anti-P. vivax vaccine 
because the presence of variant forms of P. vivax parasites 
has implications for the efficacy of vaccine formulation: 
if these two genes are seen to be more conserved, this 
would strengthen the case for further study for vaccine 
development and treatment in Thailand. The aim of this 
study was to investigate the genetic diversity of PvCSP and 
PvMSP1 genes from field isolates of malaria parasites from 
four different regions of Thailand.
2. Materials and methods
2.1. Study samples
  The finger prick blood collections on filter paper (Protein 
saver card, Whatman Inc.) from February 2008 to February 
2009 were extracted using a DNA mini blood kit (QIAGEN, 
Germany) according to the manufacturer’s instructions 
and diagnosed for P. vivax by multiplex PCR[23].  The 152 
infected P. vivax isolates from the highly endemicity at 
Tak (West) (n=66), Chanthaburi (East) (n=60), the lower 
endemicity at Prachuap Kriri Khun (South) (n=21), and 
Mae Hong Son (North) (n=5) Provinces were designated 
by regions (Figure 1A). Only study site from East is on 
Thai-Cambodia bordering whereas other three sites are 
closed to Thai-Myanmar border. P. vivax infection has 
been increased for the last few years and found more than 
half of total malaria incidence in Thailand[22]. The samples 
were collected from areas where West, East were the high 
endemicity and North, South are low endemicity (when 
compare between this study). Permission for this study was 
obtained from the ethical review committee for research 
in human subjects, Ministry of Public Health, Thailand 
(Reference no. 101/2550). 
2.2. Gene amplifications
  Oligonucleotide primers were designed using published 
sequences of PvMSP1. The assay conditions, including 
mastermix, were adapted and separately determined in the 
different primer sets[18]. All amplification reactions were 
carried out in a total volume of 50 毺L and in the presence 
of 10 mM Tris-HCl, pH 8.3, 2.5 mM MgCl2, 250 nM of each 
oligonucleotide primers, 125 毺M of each of the four dNTPs, 
and 0.4 units HotStar Taq polymerase (QIAGEN, Germany). 
Primary amplification reactions were initiated with 2 毺L
of the template genomic DNA prepared from the blood 
samples, and the 2 毺L of the product of these reactions 
was used to initiate the secondary amplification reactions. 
PvMSP1 F2 PCR products were digested by AluI enzyme. For 
the multiple clones found in PvMSP1 F2 were excluded from 
PCR-RFLP reaction.
  The CSP gene amplification protocol was adapted from 
previous study[24]. This protocol can detect three variant 
types of CSP gene, VK210, VK247, and P. vivax-like.  
2.3. Data analysis
  All PCR products were analyzed by 1.5% agarose 
gels electrophoresis staining with ethidium bromide. 
Electrophoresis was performed in TBE buffer, and then 
was visualized on ultraviolet transilluminator. The size of 
the amplified fragments was estimated by comparison to a 
100 bp ladder. Allele frequencies were estimated from PCR 
products in each gene. The proportion of single and mixed 
infections was calculated and confidence intervals were 
obtained using the modified Wald method of the on-line 
GraphPad program at http://www.graphpad.com/quickcalcs/
ConfInterval1.cfm.
3. Results  
  The genotyping data are summarized in Figure 1. There 
were no mixed genotypes in North and South for PvMSP1 
F2 and F3, respectively. However, mixed genotypes were 
found at relatively high frequencies (up to 40%) in North for 
PvMSP1 F3. In contrast most of the isolates (>90%) showed a 
single genotype for the PvCSP gene. This underestimates the 
true proportion of mixed samples because some may appear 
single at the genotyping site but are known to be mixed at 
other sites. The overall level of mixed genotypes, defined as 
heterozygous at any marker, was 25% (38/152). The PvMSP1 
gene was genotyped in two fragments; PvMSP1 F2 and PvMSP1 
F3. The number of alleles found in PvMSP1 gene is shown in 
Figure 1B. PvMSP1 F2 had 12.50% (19/152) of total amplified 
samples as multiple genotypes (95% CI 8.07 to 18.78%) and 
PvMSP1 F3 had 8.55% (13/152) of total amplified samples 
as multiple genotypes (95% CI 4.95 to 14.19%). PvCSP was 
found as multiple genotypes in 4.6% (6/152) of samples (95% 
CI 1.63 to 8.53%) (Table 1).
  The allele frequencies of PvCSP gene is shown in Figure1C. 
The results showed that the predominant variant was the 
VK210 type at a frequency of 93.42% (142/152). However, 
VK247 variant type and mixed genotypes were also found at 
frequencies of 2.63% (6/152) and 3.95% (4/152), respectively. 
P. vivax-like type was also found 1% (1/231). Pairwise 
test between the populations and genetic analysis were 
investigated whether all population differed, or whether the 
result was due to a single, genetically-distinct population 
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Table 1
The overall cases of single and multiple infections in PvMSP1 and PvCSP.
Study site
Total samples 
available
MSP1 F2 genotype MSP1 F3 genotype CSP    genotype
Single Mixed Single Mixed Single Mixed 
West 66 59 7 57 9 61 5
East 60 53 7 58 2 60 0
South 21 16 5 21 0 20 1
North 5 5 0 3 2 5 0
Total 152 133 19 139 13 146 6
Note: West = Tak, East = Chanthaburi, South = Prachup Kriri Khun, North = Mae Hong Sorn province.
Table 2
PvMSP1 F2 fragments patterns from PCR RFLP. 
Type Fragment size (bp)
A 140 280 470 - -
B 140 210 470 - -
C 140 240 270 - -
D 140 330 440 - -
E 140 280 440 590 -
F 140 170 280 430 -
G 160 210 280 430 -
H 210 280 320 440 -
I 170 190 210 250 290
J 210 270 300 390 -
K 190 210 320 - -
L 140 170 190 210 240
The size (bp) of the amplified fragments was estimated by comparison to a 100 bp ladder, there were 12 alleles showing A-L.  
Figure 1. (A) Four study regions (north=Mae Hong Sorn, west=Mae Sod, east=Chanthaburi, south=Prachuap Khiri Khun), (B) number of 
PvMSP1 allelic types in each study site, (C)  the allele frequencies of PvCSP gene in each study site.
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(data not shown). 
  Two sizes differences were found in PvMSP1 F2, identical 
to a previous study[18] (Figure 2A). Twelve alleles were 
reported after digested with Alu I enzyme (Figure 2B). Size 
of 12 patterns was shown in Table 2. Size variations were 
determined for PvMSP1 F3, from 250 bp to 390 bp (Figure 
2C). There were size variations in PvMSP1 F3 in every study 
sites except in east isolates. There were high frequency 
distribution of curtain genotype with size 270 bp suggested 
that the parasite population are likely to be under selective 
pressure than other parasites in three areas. 
300 bp
1 kb
500 bp
(A) (C)
(B)
Figure 2.  Size variations in (A) PvMSP1 F2 (B) PvMSP1 F3 (C) 
PvMSP1 F2 RFLP.
4. Discussion
  This report is one of a series of studies designed to bring 
our understanding of P. vivax genetic structure up to the 
level of that for P. falciparum. The results for PvMSP1 
indicated that there was genetic diversity in Thailand with 
more variants seen than previous studies[18,19]. 
  Even though PvMSP1 in Salvador-1 and Belem were 
successfully amplified as the positive controls, polymorphism 
in the region targeted by the PvMSP1 F1 forward primer[17] is 
the reason for the failure to amplify this marker in many 
of the isolates we tested. However, PvMSP1 F1 primer was 
excluded as they might hinder effective PCR amplification. 
This suggested that this particular marker has limited utility 
for genetic diversity studies in Thailand.
  The major limitation in this study was the use of dried 
blood spots on filter papers for the source of P. vivax DNA. 
Although the use of dried blood spot filters has many 
practical advantages for field work (i.e collected directly 
from patient finger prick and no need for cold reservation), 
the small quantity of blood (~50 毺L) and the presence of 
inhibitors significantly limits the DNA extraction yield. To 
limit this problem, parasitemia > 0.1% was included for 
sample collection. However this in itself represents a source 
of potential bias, nonetheless one that is difficult to avoid. 
Despite the above limitations, our approach for assessing 
the genetic diversity of P. vivax in Thailand was relatively 
successful and compares well to similar studies in India[19].  
However, many studies on P. vivax genetic diversity 
determined many markers on this Plasmodium sp. In 
2011, they found two new alleles and several unidentified 
dimorphic substitutions and size polymorphism in 
PvMSP1[25]. In 2010, Zeyrek et al. found the limited 
polymorphism of PvMSP1 in Turkey isolates which showed 
a remarkably lower diversity in P. vivax population than in 
populations in Thailand and Brazil[26]. Recently PvMSP5 was 
studied for genetic diversity in Colombian and comparative 
within Thai, Brazilian, Indonesian isolates[27,28]. They found 
high polymorphism in PvMSP5 exon I which was detected 
positive selection in all isolates[28]. Furthermore, PvMSP3 
and PvMSP3 were found to be reliable polymorphic marker 
for population genetic study in Thailand by using PCR-
RFLP without sequencing[29]. Many studies used PCR-
RFLP for genetic diversity study and they can confirm the 
polymorphic pattern without doing sequencing. For these 
reason, we concluded that PvMSP gene family can be used 
as a polymorphic marker and PCR-RFLP technique can be 
reliable method for genetic diversity study.
  Even the PCR-RFLP analysis might not be easy to interpret 
the allelic polymorphisms in the population but this method 
is also popular used. The size variation can be inaccurate 
when different alleles coexist in the sample. Despite recent 
advances in sequencing technology, it is still not practical 
for public health laboratories in malaria endemic regions 
to conduct regular sequencing for large scale diversity 
studies. Consequently, full sequencing was not conducted 
in this study, primarily focusing on the distribution of 
previously characterized genetic markers in Thai P. vivax, 
using appropriate molecular techniques readily available to 
researchers from limited resource settings. In summary, no 
single genetic marker is inherently good or bad makers vary 
in attributes and in their most appropriate application.
  Undoubtedly, PvCSP variant type found in this study was 
similar found  to those obtained in Papua New Guinea, 
Indonesia, Brazil, Guyana, and Madagascar[9,30], but contrast 
with the results of an earlier study by Gopinath et al. in 
1994 that did not find P. vivax-like type[31]. Most of variant 
types of PvCSP were VK210, as previously observed in 
India, Thailand, Azerbaijan, Guyana and Brazil[11,14,19,31,32]. 
Especially, mix subtypes (VK210 and VK247) were found in 
Myanmar[33] by serological test as same as in the present 
study. This implied that mixed genotypes may be distributed 
from Myanmar to Thailand. This shows that PvCSP type does 
not have extensive genetic diversity, which could be useful 
for vaccine development in Thailand.  
  The present of VK247 type may be related to the prevalence 
of different mosquito species that can contain different 
parasite genotypes or strains. In general, the mechanism 
of malaria vector and parasite interaction are different 
among the species, in addition, it could reflect parasite 
avoidance of the host immune response[34], the sampling 
bias or immune selection by the host.  Interestingly, mixed 
genotypes were found in Northern isolates using PvMSP1 F3 
but not with PvMSP1 F2. In contrast, isolates from the south 
found mixed genotypes in PvMSP1 F2 but not in PvMSP1 F3. 
This would indicate that parasites may contain mix clones 
that can be transferred into hosts which show different 
clones in one time biting of mosquito. Moreover, the protein 
variation of CSP is also dependent on the susceptibility of 
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each species of mosquito, which probably occurs during 
the ookinete and/or early oocyst stages[35]. Other work has 
confirmed that parasite population structure can result 
from the adaptation of malaria parasites to their vectors[36]. 
Furthermore, multiple genotypes may be caused by the 
time of biting of mosquitoes, which has been related to 
the range of genetic diversity exhibited by mosquitoes and 
malaria field populations[37-48]. Moreover, the problem when 
analyzing human blood samples is that humans in areas of 
moderate to high malaria transmission are often infected 
by several genetically distinct malaria clones; the number 
of clones is known as their multiplicity of infection (MOI). 
Consequently, many blood samples will have MOI>1 and 
be genetically ambiguous. Furthermore, the low sensitivity 
of genotyping should be recognized and noted that ‘minor’ 
clones (i.e. those with low parasitaemia) may be missed in 
genotyping, leading to an underestimated MOI[49]. 
  These studied genes are recognized by host’s immune 
system. Analyzes of polymorphism and population diversity 
of P. vivax have focused on parasite molecules that are 
under selection by host immunity, particularly antigens 
homologous to those of P. falciparum, such as MSP, CSP or 
erythrocyte binding antigens[11]. However, some population 
parameters are better determined by using DNA markers that 
are neutral, such as microsatellite loci[50]. 
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